Theratechnologies EV / EBITDA
Mi az Theratechnologies EV / EBITDA?
A EV / EBITDA az Theratechnologies, Inc. - N/A
Mi a EV / EBITDA meghatározása?
Az EV / EBITDA a vállalati érték a kamat, az adózás, az értékcsökkenés és az amortizáció előtti eredményekkel elosztva. Ez azt jelenti, hogy mennyire drága egy állomány, és gyakrabban érvényesül a vállalatok közötti összehasonlításnál, mint az ár / nyereség arány. Megméri az árat (vállalati érték formájában), amelyet a befektető fizet a vállalat pénzforgalmának javára (EBITDA formájában).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA a Health Care szektor a TSX-on cégekben a Theratechnologies -hoz képest
Mit csinál Theratechnologies?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
ev / ebitda -hoz hasonló cégek Theratechnologies
- Avira Resources nak EV / EBITDA N/A van
- Avalon GloboCare nak EV / EBITDA N/A van
- Westport Fuel Systems nak EV / EBITDA N/A van
- Sequana Medical NV nak EV / EBITDA N/A van
- Mint Payments nak EV / EBITDA N/A van
- FRX Innovations nak EV / EBITDA N/A van
- Theratechnologies nak EV / EBITDA N/A van
- Bubblr Inc nak EV / EBITDA N/A van
- Mithra Pharmaceuticals SA nak EV / EBITDA N/A van
- Auxly Cannabis nak EV / EBITDA N/A van
- Spey Resources Corp nak EV / EBITDA N/A van
- Golden Deeps nak EV / EBITDA N/A van
- Red Lion Hotels nak EV / EBITDA N/A van